Literature DB >> 21503878

Homeodomain transcription factors regulate BMP-2-induced osteoactivin transcription in osteoblasts.

Maneet Singh1, Fabiola E Del Carpio-Cano, M Alexandra Monroy, Steven N Popoff, Fayez F Safadi.   

Abstract

Osteoactivin (OA) is required for the differentiation of osteoblast cells. OA expression is stimulated by bone morphogenetic protein-2 (BMP-2). BMP-2 recruits homeodomain transcription factors Dlx3, Dlx5, and Msx2 to selectively activate or repress transcription of osteogenic genes and hence tightly regulate their transcription during osteoblast differentiation. Considering the key roles of Dlx3, Dlx5, and Msx2 in osteoblast differentiation, here we hypothesize that homeodomain proteins regulate BMP-2-induced OA transcription during osteoblast differentiation. Four classical homeodomain binding sites were identified in the proximal 0.96 kb region of rat OA promoter. Deletions and mutagenesis studies of the OA promoter region indicated that all four homeodomain binding sites are crucial for BMP-2-induced OA promoter activity. Simultaneous disruption of homeodomain binding sites at -852 and -843 of the transcription start site of OA gene significantly decreased the BMP-2-induced OA transcription and inhibited binding of Dlx3, Dlx5, and Msx2 proteins to the OA promoter. Dlx3 and Dlx5 proteins were found to activate the OA transcription, whereas, Msx2 suppressed BMP-2-induced OA transcription. Using chromatin immunoprecipitation assays, we demonstrated that the OA promoter is predominantly occupied by Dlx3 and Dlx5 during the proliferation and matrix maturation stages of osteoblast differentiation, respectively. During the matrix mineralization stage, BMP-2 robustly enhanced the recruitment of Dlx5 and to a lesser extent of Dlx3 and Msx2 to the OA promoter region. Collectively, our results show that the BMP-2-induced OA transcription is differentially regulated by Dlx3, Dlx5, and Msx2 during osteoblast differentiation.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21503878     DOI: 10.1002/jcp.22791

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  10 in total

1.  Dlx genes and the maintenance of bone homeostasis and skeletal integrity.

Authors:  G Levi; Y Gitton
Journal:  Cell Death Differ       Date:  2014-09       Impact factor: 15.828

Review 2.  Glycoprotein nonmetastatic melanoma protein B: A key mediator and an emerging therapeutic target in autoimmune diseases.

Authors:  Pei-Suen Tsou; Amr H Sawalha
Journal:  FASEB J       Date:  2020-05-23       Impact factor: 5.191

3.  Mutation in osteoactivin decreases bone formation in vivo and osteoblast differentiation in vitro.

Authors:  Samir M Abdelmagid; Joyce Y Belcher; Fouad M Moussa; Suzanne L Lababidi; Gregory R Sondag; Kimberly M Novak; Afif S Sanyurah; Nagat A Frara; Roshanak Razmpour; Fabiola E Del Carpio-Cano; Fayez F Safadi
Journal:  Am J Pathol       Date:  2014-01-23       Impact factor: 4.307

Review 4.  The effect of five proteins on stem cells used for osteoblast differentiation and proliferation: a current review of the literature.

Authors:  P Chatakun; R Núñez-Toldrà; E J Díaz López; C Gil-Recio; E Martínez-Sarrà; F Hernández-Alfaro; E Ferrés-Padró; L Giner-Tarrida; M Atari
Journal:  Cell Mol Life Sci       Date:  2013-04-09       Impact factor: 9.261

5.  DLX3 regulates bone mass by targeting genes supporting osteoblast differentiation and mineral homeostasis in vivo.

Authors:  J Isaac; J Erthal; J Gordon; O Duverger; H-W Sun; A C Lichtler; G S Stein; J B Lian; M I Morasso
Journal:  Cell Death Differ       Date:  2014-06-20       Impact factor: 15.828

6.  BMP-2 Induced Expression of Alx3 That Is a Positive Regulator of Osteoblast Differentiation.

Authors:  Takashi Matsumoto; Atsushi Yamada; Ryo Aizawa; Dai Suzuki; Masayuki Tsukasaki; Wataru Suzuki; Mutsuko Nakayama; Koutaro Maki; Matsuo Yamamoto; Kazuyoshi Baba; Ryutaro Kamijo
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

7.  Targeted overexpression of osteoactivin in cells of osteoclastic lineage promotes osteoclastic resorption and bone loss in mice.

Authors:  Matilda H-C Sheng; Jon E Wergedal; Subburaman Mohan; Mehran Amoui; David J Baylink; K-H William Lau
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

8.  Senescence: novel insight into DLX3 mutations leading to enhanced bone formation in Tricho-Dento-Osseous syndrome.

Authors:  Na Zhao; Dong Han; Haochen Liu; Yue Li; Sing-Wai Wong; Zhengyi Cao; Jian Xu; Xiaowei Zhang; Tao Cai; Yixiang Wang; Hailan Feng
Journal:  Sci Rep       Date:  2016-12-07       Impact factor: 4.379

9.  Beneficial impact of Gpnmb and its significance as a biomarker in nonalcoholic steatohepatitis.

Authors:  Akihiro Katayama; Atsuko Nakatsuka; Jun Eguchi; Kazutoshi Murakami; Sanae Teshigawara; Motoko Kanzaki; Tomokazu Nunoue; Kazuyuki Hida; Nozomu Wada; Tetsuya Yasunaka; Fusao Ikeda; Akinobu Takaki; Kazuhide Yamamoto; Hiroshi Kiyonari; Hirofumi Makino; Jun Wada
Journal:  Sci Rep       Date:  2015-11-19       Impact factor: 4.379

10.  Establishment of Immortalized BMP2/4 Double Knock-Out Osteoblastic Cells Is Essential for Study of Osteoblast Growth, Differentiation, and Osteogenesis.

Authors:  Li-An Wu; Feng Wang; Kevin J Donly; Andrew Baker; Chunyan Wan; Daoshu Luo; Mary MacDougall; Shuo Chen
Journal:  J Cell Physiol       Date:  2015-12-28       Impact factor: 6.384

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.